Profusa receives Nasdaq deficiency notice for MVPHS below $15M; 180-day cure period until April 2026

Profusa, Inc.

Nasdaq notified Profusa on Oct 27, 2025 that MVPHS was below $15M for 30 consecutive business days from Sep 12 to Oct 24, 2025.
Company has 180 calendar days, until April 27, 2026, to regain compliance with the MVPHS requirement.
Compliance can be regained if MVPHS closes at or above $15M for at least 10 consecutive business days.
If not compliant by April 27, 2026, Nasdaq may delist the common stock; company can appeal or apply to transfer to Nasdaq Capital Market.
Profusa intends to actively evaluate options to regain compliance within the cure period.

item 3.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-25-104814
form_type: 8-K
ticker: PFSA
cik: 0001859807
company_name: Profusa, Inc.
filed_at: 2025-11-03T23:59:59+00:00
discovered_at: 2026-05-14T18:02:40.851952+00:00
generated_at: 2026-05-17T00:56:45.035303+00:00
sec_items: ["3.01"]
event_type: regulatory
sentiment: negative
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-25-104814
json_url: https://secwatch.observer/filing/0001213900-25-104814.json
markdown_url: https://secwatch.observer/filing/0001213900-25-104814.md
text_url: https://secwatch.observer/filing/0001213900-25-104814.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1859807/000121390025104814/0001213900-25-104814-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1859807/000121390025104814/ea0263514-8k_profusa.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001213900-25-104814

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.